Stress echocardiography compared with radionuclide ventriculography in the diagnosis of cardiomyopathy in patients receiving chemotherapy for malignant tumour;Vergleich von belastungsechokardiographie und radionuklidventrikulographie in der diagnostik der kardiomyopathie bei patienten mit malignen erkrankungen unter chemotherapie

Deutsche Medizinische Wochenschrift

Volumn 122, Issue 49, 1997, Pages 1509-1515

  Leischik, R ^b   Eising, E G ^d   Katz, M ^f   Glattki, G ^c   Bruch, C ^c   Seeber, S ^a,e   Bockisch, A ^a,d   Erbel, R ^a,c  

^a UNIVERSITY OF DUISBURG ESSEN   (Germany)

^b Kardiologische Praxis   (Germany)

^c Abteilung für Kardiologie

^d Klin und Poliklin fur Nuklearmed

^e UNIVERSITY HOSPITAL ESSEN   (Germany)

^f NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTHRACYCLINE; ANTINEOPLASTIC AGENT; PERTECHNETIC ACID TC 99M; ANTINEOPLASTIC ANTIBIOTIC;

ADULT; ARTICLE; CANCER CHEMOTHERAPY; CARDIOMYOPATHY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ECHOCARDIOGRAPHY; FEMALE; HEART LEFT VENTRICLE EJECTION FRACTION; HUMAN; MAJOR CLINICAL STUDY; MALE; MALIGNANT NEOPLASTIC DISEASE; RADIOISOTOPE VENTRICULOGRAPHY; ACUTE DISEASE; AGED; ANALYSIS OF VARIANCE; BREAST TUMOR; CHEMICALLY INDUCED DISORDER; COMPARATIVE STUDY; COMPUTER PROGRAM; HEART LEFT VENTRICLE FUNCTION; HEART STROKE VOLUME; MIDDLE AGED; MYELOID LEUKEMIA; NONHODGKIN LYMPHOMA; PLASMACYTOMA; REST; SCINTISCANNING; SEMINOMA; STRESS; TESTIS TUMOR;

ACUTE DISEASE; ADULT; AGED; ANALYSIS OF VARIANCE; ANTIBIOTICS, ANTINEOPLASTIC; BREAST NEOPLASMS; CARDIOMYOPATHIES; ECHOCARDIOGRAPHY; FEMALE; HUMANS; LEUKEMIA, MYELOID; LYMPHOMA, NON-HODGKIN; MALE; MIDDLE AGED; PLASMACYTOMA; RADIONUCLIDE VENTRICULOGRAPHY; REST; SEMINOMA; SOFTWARE; STRESS; STROKE VOLUME; TESTICULAR NEOPLASMS; VENTRICULAR FUNCTION, LEFT;

EID: 0031283297     PISSN: 00120472     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2008-1047793     Document Type: Article

References (37)

1. Alexander, J., N. Dainiak, H. J. Berger, L. Goldman, D. Johnstone, L. Reduto, T. Duffy, P. Schwartz, A. Gottschalk, B. L. Zaret: Serial assessment of doxorubicin cardiotoxin with quantitative radionuclide angiography. New Engl. J. Med. 300 (1979), 278-283.
2. Anger, K., R. Erbel, W. Krebs, J. Meyer, T. Möller, P. Schweizer, O. Yarkiroglu: Die EKG-getriggerte Herzbinnenraumszintigraphie in der Diagnostik der koronaren Herzkrankheit. Prospektive Untersuchung zum Vergleich mit Kineventrikulographie und zweidimensionaler Echokardiographie. Fortschr. Röntgenstr. 139 (1983), 487-494.
3. Bland, J. M., D. G. Altman: Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 476 (1986), 307-310.
4. Bloom, K., R. Bini, C. Williams, M. Sonley, M. Gribbin: Echocardiography in adriamycin cardiotoxicity. Cancer 41 (1978), 1265-1269.
5. Bristow, M. R., J. W. Mason, M. E. Billingham, J. R. Daniels: Dose-effect and structure Function relationsships in doxorubicin cardiomyopathy. Amer. Heart J. 102 (1981), 709-718.
6. Bristow, M. R., J. W. Mason, M. E. Billingham, J. R. Daniels: Doxorubicin cardiomyopathy. Evaluation by phonocardiography, endomyocardial biopsy, and cardiac catheteriziation. Ann. intern. Med. 88 (1978), 168-175.
7. Erbel, R., P. Schweitzer, H. Lambertz, G. Henn, J. Meyer, W. Krebs, S. Effert: Echoventriculography. A simultaneous analysis of two-dimensional echocardiography and cineventriculography. Circulation 67 (1983), 205-215.
8. Ferrans, V. J.: Anthracycline cardiotoxicity. Adv. Exp. Med. Biol. 161 (1983), 519-532.
9. Fukazawa, R., S. Ogawa, T. Hirayama: Early Detection of anthracycline cardiotoxicity in children with acute leukemia using exercise based echocardiography and doppler echocardiography. Jpn. Circ. J. 58 (1994), 625-634.
10. Gorcsan, J., J. M. Lazar, D. S. Schulman, W. P. Follansbee: Comparison of left ventricular function by echocardiographic automated border detection and by radionuclide ejection fraction. Amer. J. Cardiol. 72 (1993), 810-815.
11. Gordon, E. P., I. Schnittger, P. J. Fitzgerald, P. Williams, R. P. Popp: Reproducibility of left ventricular volumes by two-dimensional echocardiography. J. Amer. Coll. Cardiol. 2 (1983), 506-513.
12. Handerson, C., L. J. Sloss, N. Jaffe, R. H. Blum, E. Frei: Serial studies of cardiac function in patients receiving Adriamycin. Cancer Treat. Rep. 62 (1978), 857-872.
13. Hecht, H. S., L. Debord, R. Shaw, R. Dunlap, C. Ryan, S. H. Stertzer, R. K. Myler: Digital supine bicycle stress echocardiography. A new technique for evaluating coronary artery disease, J. Amer. Coll. Cardiol. 21 (1993), 950-956.
14. Kemper, E., J. Farahati, M. Wolf, S. Müller, R. Becher, C. Reiners: Radionuklidventrikulographie zur Verlaufskontrolle bei kardiotoxischer Chemotherapie. Reicht die Bestimmung der Auswurffraktion in Ruhe aus? Nucl. Med. 31 (1992), A66.
15. Klewer, S. E., S. J. Goldberg, R. L. Donnerstein, R. A. Berg, J. J. Hutterer: Dobutamine Stress Echocardiography: A sensitive indicator of diminished function in asymptomatic doxorubicin-treated long-term survivors of childhood cancer. J. Amer. Coll. Cardiol. 19 (1992), 394-401.
16. Knesevitsch, P., N. H. Göldel, S. Fritsch, E. Moser: Beurteilung der Adriamycin-Kardiotoxizität mittels der Äquilibrium-Radionuklid-Ventrikulographie. Nucl. Med. 26 (1987), 206-211.
17. Leischik, R., O. Adamczewski, S. Pötter, R. Erbel, B. Lösse: Belastungsechokardiographie - ein neuer Test zur Erfassung einer antiischämischen Medikamentenwirkung. Z. Kardiol. 84 (1995), 621-632.
18. Leischik, R., C. Kuhlmann, M. Haude, J. Ge, F. Liu, R. Erbel: Improved reproducibility of quantitative analysis of left ventricular function during exercise echocardiography after intravenous injection of BY 963. Int. J. Card. Imag. 13 (1997), 387-394.
19. Leischik, R., T. Bartel, T. Möhlenkamp, C. Bruch, T. Buck, M. Haude, G. Görge, R. Erbel: Stress echocardiography. New techniques. Europ. Heart J. 18 suppl. D (1997), D49-D56.
20. Lenaz, L., J. A. Page: Cardiotoxicity of Adriamycin and related anthracyclines. Cancer Treat Rev. 3 (1976), 111-120.
21. Lippschultz, S. E., S. P. Sanders, A. M. Goorin, J. P. Krischer, S. E. Sallan, S. D. Colan: Monitoring for Anthracycline Cardiotoxicity. Pediatrics 93 (1994), 433-437.
22. Madanay, D., M. Cerqueira, A. Jacobson, D. Matsuoka, M. Matsuda, J. R. Stratton: Radionuclide ventriculographic quantitation of left ventricular dimensions. Clin. Nucl. Med. 16 (1991), 588-592.
23. McKillop, J. H., M. R. Bristow, M. Goris, M. E. Billingham, K. Boccemuehl: Sensitivity and specifity of radionuclide ejections fractions in doxirubicin cardiotoxicity. Amer. Heart J. 106 (1986), 1048-1056.
24. Mertes, H., R. Erbel, U. Nixdorff, S. Mohr-Kahaly, S. Krüger, J. Meyer: Exercise Echocardiography for evaluation of patients after nonsurgical coronary artery revascularization. J. Amer. Coll. Cardiol. 21 (1993), 1087-1093.
25. Mertes, H., U. Nixdorf, R. Erbel, J. Meyer: Normalwerte der globalen und regionalen Myokardfunktion für die Belastungsechokardiographie. Z. Kardiol. 80 (1991), 529-536.
26. Mertes, U., R. Erbel, U. Nixdorff, S. Mohr-Kahaly, D. Wilfinger, J. Meyer: Belastungsechokardiographie. Eine sensitive Methode in der Diagnostik der koronaren Herzkrankheit. Herz 16 (1991), 355-366.
27. Minow, R. A., R. S. Benjamin, J. A. Gottlieb: Adriamycin (NSC-123 127) cardiomyopathy. An overview with determination of risk factors. Cancer Chemother. Rep. 6 (1975), 195-201.
28. Rost, R., K. W. Schneider, N. Stegman: Vergleichende echokardiographische Untersuchungen am Herzen des Leistungssportlers und des Nichttrainierten. Med. Welt 23 (1972), 1088-1093.
29. Reiners, Chr., D. Kemper, J. Farahati, M. Wolf, S. T. Müller, R. Becher: Radionuklidventrikulographie zur individuellen Steuerung der Chemotherapie mit kardiotoxischen Zystostatika. Nucl. Med. 15 (1992), 157-165.
30. Scheulen, M. E.: Kardiotoxische Nebenwirkungen von Zytostatika. Die Anthrazyklin-Kardiotoxizität. Münch. Med. Wschr. 127 (1985), 862-866.
31. Schnittger, I., P. G. Fitzgerald, G. T. Daughters, N. B. Ingels, N. E. Kantrowitz, A. Schwarzkopf, C. W. Mead, R. L. Popp: Limitations of comparing left ventricular volumes by two-dimensional echocardiography, myocardial markers, and cineangiography. Amer. J. Cardiol. 50 (1982), 512-519.
32. Steinherz, L. J., T. Graham, R. Hurwitz, H. M. Sondheimer, R. G. Schwartz, E. M. Shaffer, G. Sandor, L. Benson, R. Williams: Guidelines for cardiac monitoring of children during and after anthracycline therapy: Report of the cardiology commitee of the childrens cancer study group. Pediatrics 89 (1992), 942-949.
33. Stoddard, M. F., J. Seeger, N. E. Liddell, T. J. Hadley, D. M. Sullivan, J. Kupersmith: Prolongation of isovolumetric relaxation time as assessed by doppler echocardiography predicts doxorubicin-induced systolic dysfunction in humans. J. Amer. Coll. Cardiol. 20 (1992), 62-9.
34. Upton, M. T., S. K. Rerych, G. E. Newman, E. P. Bounous jr, R. H. Jones: The reproducibility of radionuclide angiographic measurements of left ventricular function in normal subjects at rest and during exercise. Circulation 62 (1980), 126-132.
35. Von Hoff, D. D., M. W. Layard, P. Basa, H. J. Davis jr., A. L. Von Hoff, M. Rozenzweig, F. M. Muggia: Risk factors for doxorubicin-induced congestive heart failure. Ann. intern. Med. 91 (1979), 710-717.
36. Von Hoff, D. D., M. Rozenzweig, M. Piccart: The cardiotoxicity of anticancer agents. Semin. Oncol. 9 (1982), 23-33.
37. Weesner, K. M.: B. S. Bledsoe, A. Chauvenet, M. Wofford: Exercise echocardiography in the detection of anthracycline cardiotoxicity. Cancer 68 (1991), 435-438.